Clin2
NCT07537686Likely a fitNot yet recruiting

GLP-2 Treatment for Gut Health in Undernourished Women

Environmental Enteric Dysfunction

Part of Digestive system, Hormones & metabolism clinical trials.

This study tests whether a medication called GLP-2 (given as daily injections for one month) can help repair gut damage and improve nutrition in underweight women. You would also receive food and vitamin supplements, and have two small procedures to check your gut health.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
55 people
Ages
18 years to 35 years
Study type
Interventional

Who can take part

  • You are a woman between 18 and 35 years old
  • You are underweight (BMI between 16–18.5, which means your weight is low for your height)
  • You have not taken antibiotics in the past month
  • You are willing to receive nutritional support and daily injections for one month
  • You agree to two endoscopy procedures (small cameras passed down your throat to look at your gut) with small tissue samples taken
  • You are willing to provide blood and stool samples throughout the 4-month study

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05862363Recruiting
Food and samples study in underweight pregnancy and indigestion

This study looks at how food support and sample testing might affect gut and stomach health in women who are underweight or have “functional dyspepsia,” including during pregnancy. It may help researchers learn whether this approach improves digestive symptoms and related health markers for mothers and babies.

Dhaka, Dhaka Division
NCT05311436Recruiting
Nutrition program study for slum residents in Dhaka

This study tests a nutrition program for pregnant women, adolescent girls, and young children living in Dhaka slums. It is designed to support healthier nutrition during a key growth or pregnancy period.

Dhaka, Dhaka Division
NCT06973304Recruiting· Phase 3
Teduglutide for short bowel syndrome in Chinese adults

This study tests a medicine called teduglutide for adults in China with short bowel syndrome who need long-term IV nutrition or fluids (parenteral support). The goal is to see if teduglutide can help them reduce or stop the need for these IV treatments.

Changping, Beijing Municipality
NCT07319832Recruiting
Teduglutide study for children with short bowel syndrome

This trial tests the medicine teduglutide in children (ages 1–17) with Short Bowel Syndrome who need IV nutrition. The goal is to see if teduglutide can help them reduce or stop IV nutrition.

Guangzhou, Guangdong
NCT07437911Recruiting
Can a Supplement Help with Nutrient Gaps for GLP-1 Users?

This study tests whether a daily supplement can help fill nutrient gaps and improve gut health for people who are already taking GLP-1 weight-loss medications (like Ozempic or Wegovy). Participants must be on a stable dose for at least 8 weeks and be generally healthy without other chronic conditions.

Santa Monica, California
NCT07130396Not yet recruiting
Multivitamin and probiotic for gut health on GLP-1 meds

This study tests whether taking a special multivitamin and probiotic can improve gut health in people who are already taking a GLP-1 medication. It lasts about 12 weeks and involves taking the supplements daily.

Hear when a new Environmental Enteric Dysfunction trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.